Zepbound Savings Card 2026: Terms, Eligibility, and How to Enroll

The Zepbound savings card is Eli Lilly's manufacturer copay program — the single biggest legitimate discount on Zepbound for people with the right insurance, and completely useless for everyone else. The terms are published in fine print on Lilly's own pages; this article translates them into plain numbers: what you'll actually pay, where the caps bite, who is excluded and why, and how to fix a card that gets rejected at the pharmacy counter.

Direct answer: With commercial insurance that covers Zepbound single-dose pens, the savings card drops your cost to as little as $25 per fill for a 1-, 2-, or 3-month prescription. Savings are capped at $100 per 1-month fill ($200 per 2-month, $300 per 3-month) and a separate $1,300 maximum per calendar year, across up to 13 fills. If your commercial plan does not cover Zepbound, the card switches to a different track: the multi-dose KwikPen for $299/month (2.5 mg), $399 (5 mg), or $449 (7.5–15 mg). Government plans — Medicare, Medicaid, TRICARE, VA — are excluded entirely. The current card expires December 31, 2026.

If you want the full menu of discounts beyond the official card — GoodRx prices, self-pay vials, telehealth routes — that's covered in our companion piece, every legit Zepbound coupon in 2026. This page goes deep on the Lilly program only.

Zepbound Savings Card Terms at a Glance

Two definitions worth knowing because pharmacies apply them literally: one month is 28 days and up to four single-dose pens (or one KwikPen), and the card is not insurance — it's a manufacturer subsidy that rides on top of (or substitutes for) your plan's claim.

How the $25 Zepbound Coupon Card Actually Works

"As little as $25" hides the cap math. The card pays the difference between your plan's copay and $25 — but never more than $100 per monthly fill. So:

The $25 headline holds only while your copay is $125/month or less. Above that, you pay copay minus $100. The annual ceiling is consistent with the monthly one: 13 fills × $100 = $1,300 per calendar year, after which the card contributes nothing until January.

High-deductible plan? Early in the year your "copay" may be the full list price, which blows far past the $100 cap — the card helps least exactly when the bill is biggest. Check how your plan structures GLP-1 cost-sharing in our GLP-1 insurance coverage guide.

Zepbound Savings Card Eligibility in 2026

You qualify for the $25 track if all of these are true:

• You have commercial (private/employer) drug insurance that covers Zepbound single-dose pens
• Your prescription is for an FDA-approved use — chronic weight management or obstructive sleep apnea
• You are 18 or older and a resident of the US or Puerto Rico
• You are not enrolled in any government-funded program: Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, or any state prescription drug assistance program
• You provide a valid HIPAA authorization during enrollment

If your commercial plan exists but excludes Zepbound, you drop to the $299–$449 KwikPen track below. If you have no insurance at all, the card isn't for you — but Lilly's self-pay vial program charges the same $299–$449 (see the coupon overview for that route and how it compares to the cheapest GLP-1 options overall).

Why Medicare and Government Plans Are Excluded

This isn't Lilly being stingy — it's federal law. The Anti-Kickback Statute treats manufacturer copay subsidies on government-funded prescriptions as an inducement to use a more expensive drug at taxpayer expense, so every brand copay card in the US carries the same exclusion. Medicare Part D members can't use the Zepbound card, period. Their realistic options are paying cash through LillyDirect ($299–$449/month) or a free discount card processed instead of their Part D benefit — both covered in the coupon survey.

How to Enroll in the Lilly Zepbound Savings Program

Enrollment takes minutes; the prep is what saves you a wasted pharmacy trip:

1. Confirm coverage first. Call the member line on your insurance card and ask whether Zepbound single-dose pens are on the formulary, and whether prior authorization is required. The card cannot fix a missing prior auth.
2. Go to zepbound.lilly.com/savings and answer the eligibility questionnaire (insurance type, government-plan status, age).
3. Sign the HIPAA authorization — participation requires it.
4. Save the card (download, print, or send to your phone) and bring it with your prescription.
5. Hand it to the pharmacist. It processes as a secondary claim after your insurance. If you fill by mail order, call the pharmacy and ask them to add the card's BIN/PCN/Group numbers to your profile.

The card applies at essentially any US retail pharmacy that can process secondary claims — there is no Lilly-only pharmacy network for the $25 track.

No Coverage? The $299–$449 KwikPen Track

If you're commercially insured but your plan excludes Zepbound, the savings card still prices the Zepbound KwikPen — a single multi-dose pen holding four weekly doses — at $299/month for 2.5 mg, $399 for 5 mg, and $449 for 7.5, 10, 12.5, and 15 mg. On the higher doses, the discounted price requires refilling within 45 days of your previous fill's delivery date; outside the window, regular self-pay prices of $499–$699 apply. Pen needles are sold separately and a new one is required each week.

This track exists because Lilly would rather sell you the drug near its direct-to-consumer price than lose you entirely — the numbers deliberately match the LillyDirect Self Pay Journey Program.

Denied because your plan excludes weight-loss drugs — or no insurance at all? Yücca telehealth — online evaluation, doctor-prescribed compounded Tirzepatide+ or Semaglutide+ filled by a licensed US pharmacy, from $146/month. Cheaper than any coupon route on this page. (Partner link: we may earn a commission, at no extra cost to you.)

Zepbound Discount Card Expiration and Renewal

The card printed today expires December 31, 2026, and the $1,300 annual savings pool resets each calendar year. Practical implications:

• Re-enroll every January. Expired cards reject silently at the register; downloading a fresh card takes two minutes.
• Lilly can change or kill the program at any time, with or without notice — the terms say so explicitly. The structure has held through 2026 so far, but nothing is contractually guaranteed.
• The 13-fill limit matters mostly for people filling monthly plus an early vacation override; a standard 12-fills-a-year patient never touches it.

Troubleshooting: Savings Card Denied at the Pharmacy

The card rejects for a handful of predictable reasons:

• You're on a government plan — even as secondary coverage. Any Medicare/Medicaid enrollment disqualifies you. No workaround exists.
• Your plan doesn't actually cover Zepbound. The $25 track requires a paid primary claim. Ask the pharmacist whether the insurance rejected it (exclusion or missing prior authorization) before blaming the card.
• Prior authorization not on file. The card processes only after insurance pays; chase the PA with your prescriber first.
• Annual cap exhausted. If the card has already paid out $1,300 this calendar year, it contributes $0 until January.
• Expired card. Re-download at zepbound.lilly.com/savings.
• Processing error. Pharmacies occasionally run the card as primary. Ask them to re-run it as a secondary claim with the card's BIN/PCN.

If the root cause is "plan excludes weight-loss drugs," your appeal options run through your employer's benefits team — or you pivot to the $299–$449 cash tracks.

Zepbound Savings Card 2026 vs 2025: What Changed

The card's core structure — $25 per fill, $100/$200/$300 monthly caps, $1,300 annual maximum — carried over from 2025 into 2026 intact, with the expiration date rolled forward to 12/31/2026. The real movement was on the non-covered and self-pay side: effective December 1, 2025, Lilly cut the cash prices from $349 to $299 (2.5 mg), $499 to $399 (5 mg), and $499 to $449 (7.5–15 mg), and those lower prices define the card's non-covered KwikPen track in 2026. If you priced Zepbound in mid-2025 and walked away, the no-coverage math is $50–$100/month better now.

Frequently asked questions

How much is Zepbound with the savings card? As little as $25 per fill if your commercial plan covers Zepbound and your copay is $125/month or under. With a higher copay you pay copay minus $100. Without coverage, the KwikPen track runs $299–$449/month.

What is the maximum savings on the Zepbound savings card? $100 per 1-month fill ($200 per 2-month, $300 per 3-month) and $1,300 per calendar year, across a maximum of 13 fills.

When does the Zepbound savings card expire? The current card expires December 31, 2026. Annual caps reset each calendar year, and you should re-download the card every January. Lilly reserves the right to amend or end the program at any time.

Why was my Zepbound savings card denied? Most often: a government plan on file, no prior authorization, a plan that excludes Zepbound, the $1,300 annual cap already spent, or an expired card. Ask the pharmacist whether the rejection came from your insurance or from the card — the fixes are different.

Does the savings card work on Zepbound vials? The $25 track applies to single-dose pens; the non-covered track applies to the KwikPen. Vials are sold through Lilly's separate Self Pay Journey Program at the same $299–$449 — details in our Zepbound coupon overview.

Can I use the savings card with Medicare Part D? No. Federal anti-kickback rules exclude all government plans. Note the card also doesn't transfer to Mounjaro, which has its own program — see Mounjaro vs Zepbound. Cross-drug savings options are in our GLP-1 coupons and savings guide.

Last reviewed: June 13, 2026

Sources

• Savings Options — Zepbound (tirzepatide), Eli Lilly
• Coverage, Affordability, and Savings — Zepbound (tirzepatide), Eli Lilly
• Authentic Zepbound Shipped to You — LillyDirect
• Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients — PharmExec
• Zepbound 2026 Prices, Coupons & Savings Tips — GoodRx

References

• Zepbound (tirzepatide) label — DailyMed, NIH — FDA label confirming Zepbound's approved uses: chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity.
• Tirzepatide — StatPearls, NCBI Bookshelf — independent medical overview confirming tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist.
• Zepbound Savings Options — Eli Lilly — official manufacturer savings-card terms and enrollment.